Compare PETZ & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PETZ | HKPD |
|---|---|---|
| Founded | 2002 | 2016 |
| Country | China | Hong Kong |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0M | 10.6M |
| IPO Year | 2017 | 2025 |
| Metric | PETZ | HKPD |
|---|---|---|
| Price | $1.02 | $0.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.1K | ★ 141.1K |
| Earning Date | 11-13-2025 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | $1,046,006.00 | ★ $20,313,818.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.33 | ★ N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $0.65 | $0.68 |
| 52 Week High | $1.68 | $3.79 |
| Indicator | PETZ | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 58.90 | 41.79 |
| Support Level | $0.90 | $0.76 |
| Resistance Level | $1.03 | $0.90 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 100.00 | 40.43 |
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.